Ft

Takeda Pharmaceutical posts second quarter net loss

Takeda Pharmaceutical posts second quarter net loss


Updated October 26, 2023 at 4:44 a.m. ET

Takeda Pharmaceutical reported a net loss in the second quarter due to impairment losses on certain products and reduced its net profit forecast for the year ending March 2024.

The Japanese pharmaceutical maker announced Thursday that it posted a net loss of 48.0 billion yen ($319.5 million) for the quarter ended September 30. This compares to the estimated net income of 70.41 billion yen according to a survey of analysts by Quick and net income. of 61.7 billion yuan during the previous year period.

Copyright ©2023 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8


Wj

Eleon

With a penchant for words, Eleon Smith began writing at an early age. As editor-in-chief of his high school newspaper, he honed his skills telling impactful stories. Smith went on to study journalism at Columbia University, where he graduated top of his class. After interning at the New York Times, Smith landed a role as a news writer. Over the past decade, he has covered major events like presidential elections and natural disasters. His ability to craft compelling narratives that capture the human experience has earned him acclaim. Though writing is his passion, Eleon also enjoys hiking, cooking and reading historical fiction in his free time. With an eye for detail and knack for storytelling, he continues making his mark at the forefront of journalism.
Back to top button